# Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty

> **NCT02863120** · PHASE4 · COMPLETED · sponsor: **Texas Orthopaedics, Sports and Rehabilitation Associates** · enrollment: 63 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** liposomal bupivacaine
- **DRUG:** bupivacaine HCl
- **DRUG:** Ropivacaine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02863120
- **Lead sponsor:** Texas Orthopaedics, Sports and Rehabilitation Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02863120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02863120, "Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02863120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*